Report Detail
Global Regenerative Medicine Market Size, Status and Forecast 2019-2025
- RnM2840415 |
- 28 February, 2019 |
- Global |
- 108 Pages |
- QYResearch |
- Other
Regenerative medicine is a branch of translational research in tissue engineering and molecular biology which deals with the "process of replacing, engineering or regenerating human cells, tissues or organs to restore or establish normal function". It is through the use of innovative medical means rebuilding diseased or damaged tissue or to support diseased or damaged tissue regeneration. The methods used include cell therapy, tissue engineering, chemically induced and therapeutic cloning, etc. Any combination of these technologies may be used to harness or stimulate the body’s innate healing ability in order to treat a wide range of ailments, including musculoskeletal-related conditions, cardio- and peripheral vascular diseases, neurological disorders, stroke, non-healing wounds and ocular diseases.
Currently, some companies in the world can provide regenerative medicine service, mainly concentrating in USA. The main market players are DePuy Synthes, Medtronic, ZimmerBiomet, Stryker, Acelity, MiMedx Group, Organogenesis, UniQure, Cellular Dynamics International, etc.
USA is the largest market of regenerative medicine, which occupies 51.09 percent of global regenerative medicine market share in 2015. It is followed by EU, which has around 16.66 percent of the global total industry. Other main regions which take important part in this industry include Japan and China.
According to the research, the most potential market in the main countries of regenerative medicine industry is Asia, determined by the rising level of medical care. Besides, South America, Middle East should also be focused by the investors. They are the potential consumers of regenerative medicine.
Despite the presence of competition problems, due to the huge industry profits, investors are still optimistic about this area; there will be more investments to enter the field.
The relatively-mature technology is cell transplantation; tissue engineering and therapeutic cloning has its technical advantages, which is the direction of future research and development.
In 2018, the global Regenerative Medicine market size was 5350 million US$ and it is expected to reach 28800 million US$ by the end of 2025, with a CAGR of 23.4% during 2019-2025.
This report focuses on the global Regenerative Medicine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Regenerative Medicine development in United States, Europe and China.
The key players covered in this study
DePuy Synthes
Medtronic
ZimmerBiomet
Stryker
Acelity
MiMedx Group
Organogenesis
UniQure
Cellular Dynamics International
Osiris Therapeutics
Vcanbio
Gamida Cell
Golden Meditech
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
Stemcell Technologies
Bellicum Pharmaceuticals
Market segment by Type, the product can be split into
Cell Therapy
Tissue Engineering
Biomaterial
Other
Market segment by Application, split into
Dermatology
Cardiovascular
CNS
Orthopedic
Others
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Regenerative Medicine status, future forecast, growth opportunity, key market and key players.
To present the Regenerative Medicine development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Regenerative Medicine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Key Market Segments
- 1.3 Players Covered
- 1.4 Market Analysis by Type
- 1.4.1 Global Regenerative Medicine Market Size Growth Rate by Type (2014-2025)
- 1.4.2 Cell Therapy
- 1.4.3 Tissue Engineering
- 1.4.4 Biomaterial
- 1.4.5 Other
- 1.5 Market by Application
- 1.5.1 Global Regenerative Medicine Market Share by Application (2014-2025)
- 1.5.2 Dermatology
- 1.5.3 Cardiovascular
- 1.5.4 CNS
- 1.5.5 Orthopedic
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Global Growth Trends
- 2.1 Regenerative Medicine Market Size
- 2.2 Regenerative Medicine Growth Trends by Regions
- 2.2.1 Regenerative Medicine Market Size by Regions (2014-2025)
- 2.2.2 Regenerative Medicine Market Share by Regions (2014-2019)
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
- 2.3.3 Market Opportunities
3 Market Share by Key Players
- 3.1 Regenerative Medicine Market Size by Manufacturers
- 3.1.1 Global Regenerative Medicine Revenue by Manufacturers (2014-2019)
- 3.1.2 Global Regenerative Medicine Revenue Market Share by Manufacturers (2014-2019)
- 3.1.3 Global Regenerative Medicine Market Concentration Ratio (CR5 and HHI)
- 3.2 Regenerative Medicine Key Players Head office and Area Served
- 3.3 Key Players Regenerative Medicine Product/Solution/Service
- 3.4 Date of Enter into Regenerative Medicine Market
- 3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
- 4.1 Global Regenerative Medicine Market Size by Type (2014-2019)
- 4.2 Global Regenerative Medicine Market Size by Application (2014-2019)
5 United States
- 5.1 United States Regenerative Medicine Market Size (2014-2019)
- 5.2 Regenerative Medicine Key Players in United States
- 5.3 United States Regenerative Medicine Market Size by Type
- 5.4 United States Regenerative Medicine Market Size by Application
6 Europe
- 6.1 Europe Regenerative Medicine Market Size (2014-2019)
- 6.2 Regenerative Medicine Key Players in Europe
- 6.3 Europe Regenerative Medicine Market Size by Type
- 6.4 Europe Regenerative Medicine Market Size by Application
7 China
- 7.1 China Regenerative Medicine Market Size (2014-2019)
- 7.2 Regenerative Medicine Key Players in China
- 7.3 China Regenerative Medicine Market Size by Type
- 7.4 China Regenerative Medicine Market Size by Application
8 Japan
- 8.1 Japan Regenerative Medicine Market Size (2014-2019)
- 8.2 Regenerative Medicine Key Players in Japan
- 8.3 Japan Regenerative Medicine Market Size by Type
- 8.4 Japan Regenerative Medicine Market Size by Application
9 Southeast Asia
- 9.1 Southeast Asia Regenerative Medicine Market Size (2014-2019)
- 9.2 Regenerative Medicine Key Players in Southeast Asia
- 9.3 Southeast Asia Regenerative Medicine Market Size by Type
- 9.4 Southeast Asia Regenerative Medicine Market Size by Application
10 India
- 10.1 India Regenerative Medicine Market Size (2014-2019)
- 10.2 Regenerative Medicine Key Players in India
- 10.3 India Regenerative Medicine Market Size by Type
- 10.4 India Regenerative Medicine Market Size by Application
11 Central & South America
- 11.1 Central & South America Regenerative Medicine Market Size (2014-2019)
- 11.2 Regenerative Medicine Key Players in Central & South America
- 11.3 Central & South America Regenerative Medicine Market Size by Type
- 11.4 Central & South America Regenerative Medicine Market Size by Application
12 International Players Profiles
- 12.1 DePuy Synthes
- 12.1.1 DePuy Synthes Company Details
- 12.1.2 Company Description and Business Overview
- 12.1.3 Regenerative Medicine Introduction
- 12.1.4 DePuy Synthes Revenue in Regenerative Medicine Business (2014-2019)
- 12.1.5 DePuy Synthes Recent Development
- 12.2 Medtronic
- 12.2.1 Medtronic Company Details
- 12.2.2 Company Description and Business Overview
- 12.2.3 Regenerative Medicine Introduction
- 12.2.4 Medtronic Revenue in Regenerative Medicine Business (2014-2019)
- 12.2.5 Medtronic Recent Development
- 12.3 ZimmerBiomet
- 12.3.1 ZimmerBiomet Company Details
- 12.3.2 Company Description and Business Overview
- 12.3.3 Regenerative Medicine Introduction
- 12.3.4 ZimmerBiomet Revenue in Regenerative Medicine Business (2014-2019)
- 12.3.5 ZimmerBiomet Recent Development
- 12.4 Stryker
- 12.4.1 Stryker Company Details
- 12.4.2 Company Description and Business Overview
- 12.4.3 Regenerative Medicine Introduction
- 12.4.4 Stryker Revenue in Regenerative Medicine Business (2014-2019)
- 12.4.5 Stryker Recent Development
- 12.5 Acelity
- 12.5.1 Acelity Company Details
- 12.5.2 Company Description and Business Overview
- 12.5.3 Regenerative Medicine Introduction
- 12.5.4 Acelity Revenue in Regenerative Medicine Business (2014-2019)
- 12.5.5 Acelity Recent Development
- 12.6 MiMedx Group
- 12.6.1 MiMedx Group Company Details
- 12.6.2 Company Description and Business Overview
- 12.6.3 Regenerative Medicine Introduction
- 12.6.4 MiMedx Group Revenue in Regenerative Medicine Business (2014-2019)
- 12.6.5 MiMedx Group Recent Development
- 12.7 Organogenesis
- 12.7.1 Organogenesis Company Details
- 12.7.2 Company Description and Business Overview
- 12.7.3 Regenerative Medicine Introduction
- 12.7.4 Organogenesis Revenue in Regenerative Medicine Business (2014-2019)
- 12.7.5 Organogenesis Recent Development
- 12.8 UniQure
- 12.8.1 UniQure Company Details
- 12.8.2 Company Description and Business Overview
- 12.8.3 Regenerative Medicine Introduction
- 12.8.4 UniQure Revenue in Regenerative Medicine Business (2014-2019)
- 12.8.5 UniQure Recent Development
- 12.9 Cellular Dynamics International
- 12.9.1 Cellular Dynamics International Company Details
- 12.9.2 Company Description and Business Overview
- 12.9.3 Regenerative Medicine Introduction
- 12.9.4 Cellular Dynamics International Revenue in Regenerative Medicine Business (2014-2019)
- 12.9.5 Cellular Dynamics International Recent Development
- 12.10 Osiris Therapeutics
- 12.10.1 Osiris Therapeutics Company Details
- 12.10.2 Company Description and Business Overview
- 12.10.3 Regenerative Medicine Introduction
- 12.10.4 Osiris Therapeutics Revenue in Regenerative Medicine Business (2014-2019)
- 12.10.5 Osiris Therapeutics Recent Development
- 12.11 Vcanbio
- 12.12 Gamida Cell
- 12.13 Golden Meditech
- 12.14 Cytori
- 12.15 Celgene
- 12.16 Vericel Corporation
- 12.17 Guanhao Biotech
- 12.18 Mesoblast
- 12.19 Stemcell Technologies
- 12.20 Bellicum Pharmaceuticals
13 Market Forecast 2019-2025
- 13.1 Market Size Forecast by Regions
- 13.2 United States
- 13.3 Europe
- 13.4 China
- 13.5 Japan
- 13.6 Southeast Asia
- 13.7 India
- 13.8 Central & South America
- 13.9 Market Size Forecast by Product (2019-2025)
- 13.10 Market Size Forecast by Application (2019-2025)
14 Analyst's Viewpoints/Conclusions
15 Appendix
- 15.1 Research Methodology
- 15.1.1 Methodology/Research Approach
- 15.1.1.1 Research Programs/Design
- 15.1.1.2 Market Size Estimation
- 12.1.1.3 Market Breakdown and Data Triangulation
- 15.1.2 Data Source
- 15.1.2.1 Secondary Sources
- 15.1.2.2 Primary Sources
- 15.1.1 Methodology/Research Approach
- 15.2 Disclaimer
Summary:
Get latest Market Research Reports on Regenerative Medicine . Industry analysis & Market Report on Regenerative Medicine is a syndicated market report, published as Global Regenerative Medicine Market Size, Status and Forecast 2019-2025. It is complete Research Study and Industry Analysis of Regenerative Medicine market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
